|
Volumn 70, Issue 63, 2005, Pages 17167-17192
|
Use of ozone-depleting substances; removal of essential-use designations. Final rule.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
CHLOROFLUOROCARBON;
OZONE;
SALBUTAMOL;
AIR POLLUTANT;
AIR POLLUTION;
ARTICLE;
ASTHMA;
CLASSIFICATION;
COST;
ECONOMICS;
GOVERNMENT;
HUMAN;
LEGAL ASPECT;
MEDICAID;
MEDICARE;
METERED DOSE INHALER;
UNITED STATES;
ADRENERGIC BETA-AGONISTS;
AIR POLLUTANTS;
AIR POLLUTION;
ALBUTEROL;
ASTHMA;
CHLOROFLUOROCARBONS;
COSTS AND COST ANALYSIS;
HUMANS;
MEDICAID;
MEDICARE;
METERED DOSE INHALERS;
OZONE;
UNITED STATES;
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY;
|
EID: 16244369778
PISSN: 00976326
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (19)
|
References (0)
|